Form 8-K - Current report:
SEC Accession No. 0001213900-17-011849
Filing Date
2017-11-13
Accepted
2017-11-13 16:14:14
Documents
2
Period of Report
2017-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k111317b_immucellcorp.htm 8-K 23618
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED NOVEMBER 13, 2017 f8k111317bex99-1_immucell.htm EX-99.1 63770
  Complete submission text file 0001213900-17-011849.txt   88478
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 171196011
SIC: 2835 In Vitro & In Vivo Diagnostic Substances